61-75 of 622
Rethinking Treatment Success in Irritable Bowel Syndrome with Constipation
Clinician's RoundtableRethinking Treatment Success in Irritable Bowel Syndrome with Constipation
Brian P. McDonough, MD, FAAFP
Darren Brenner, MD
Mechanism Matters: Retainagogues in IBS-C Care
Clinician's RoundtableMechanism Matters: Retainagogues in IBS-C Care
Brian P. McDonough, MD, FAAFP
Darren Brenner, MD
Rethinking Disease Monitoring in Primary Biliary Cholangitis
GI InsightsRethinking Disease Monitoring in Primary Biliary Cholangitis
Alexandria May, PharmD, BCPS
Vinod Rustgi, MD
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Charles Turck, PharmD, BCPS, BCCCP
Aparna R. Parikh, MD
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Stacey Cohen, MD
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Project Oncology®ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Charles Turck, PharmD, BCPS, BCCCP
Pooja Ghatalia, MD
- advertisement
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
On the Frontlines of Colorectal CancerCRC Screening Strategies: Balancing Accuracy, Access, and Adherence
Ryan Quigley
Samuel Muench, MD
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Ryan Quigley
Samuel Muench, MD
Why Adenoma Detection Rate Matters in Colorectal Cancer Screening
Clinician's RoundtableWhy Adenoma Detection Rate Matters in Colorectal Cancer Screening
Brian P. McDonough, MD, FAAFP
Renee Williams, MD, GI
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Brian P. McDonough, MD, FAAFP
Richard Kim, MD
Beyond Lab Values: Understanding Symptom Burden in Primary Biliary Cholangitis
GI InsightsBeyond Lab Values: Understanding Symptom Burden in Primary Biliary Cholangitis
Steve Jackson, PharmD
Alan Bonder, MD
Evaluating Biochemical Response in Primary Biliary Cholangitis
GI InsightsEvaluating Biochemical Response in Primary Biliary Cholangitis
Steve Jackson, PharmD
Alan Bonder, MD
- advertisement
Evolving Approaches to Early-Onset CRC Detection
On the Frontlines of Colorectal CancerEvolving Approaches to Early-Onset CRC Detection
Peter Buch, MD, FACG, AGAF, FACP
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Marwan G. Fakih, MD
Closing Gaps in CRC Screening: Patient-Centered Strategies
On the Frontlines of Colorectal CancerClosing Gaps in CRC Screening: Patient-Centered Strategies
Peter Buch, MD, FACG, AGAF, FACP
